Meg Elias
Corporate Officer/Principal bij ARCUTIS BIOTHERAPEUTICS, INC.
Profiel
Meg Elias is currently the Vice President of Clinical Operations at Arcutis Biotherapeutics, Inc. Her former position was as Head of Clinical Operations at Kite Pharma, Inc. She received her undergraduate degree from Cedar Crest College.
Actieve functies van Meg Elias
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2019 |
Eerdere bekende functies van Meg Elias
| Bedrijven | Functie | Einde |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01-12-2018 |
Opleiding van Meg Elias
| Cedar Crest College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
